Candice Lima Santos1, Ariani Impieri Souza2,3, José Natal Figueiroa3, Suely Arruda Vidal3. 1. Department of Oncology, Instituto de Medicina Integral Prof. Fernando Figueira, Recife, Brazil. 2. Medical School, Faculdade Pernambucana de Saúde, Recife, PE, Brazil. 3. Department of Research, Instituto de Medicina Integral Prof. Fernando Figueira, Recife, Brazil.
Abstract
OBJECTIVE: The main objective of the present study was to estimate the annual treatment costs of invasive cervical cancer (ICC) per patient at an oncology center in Brazil from a societal perspective by considering direct medical, direct nonmedical, and indirect costs. METHODS: A cost analysis descriptive study, in which direct medical, direct nonmedical, and indirect costs were collected using a microcosting approach, was conducted between May 2014 and July 2016 from a societal perspective. The study population consisted of women diagnosed with ICC admitted to a tertiary hospital in Recife, state of Pernambuco, Brazil. The annual cost per patient was estimated in terms of the value of American Dollars (US$) in 2016. RESULTS: From a societal perspective, the annual ICC treatment cost per patient was US$ 2,219.73. Direct medical costs were responsible for 81.2% of the total value, of which radiotherapy and outpatient chemotherapy had the largest share. Under the base-case assumption, the estimated cost to the national budget of a year of ICC treatment in the Brazilian population was US$ 25,954,195.04. CONCLUSION: We found a high economic impact of health care systems treating ICC in a poor region of Brazil. These estimates could be applicable to further evaluations of the cost-effectiveness of preventing and treating ICC. Thieme Revinter Publicações Ltda Rio de Janeiro, Brazil.
OBJECTIVE: The main objective of the present study was to estimate the annual treatment costs of invasive cervical cancer (ICC) per patient at an oncology center in Brazil from a societal perspective by considering direct medical, direct nonmedical, and indirect costs. METHODS: A cost analysis descriptive study, in which direct medical, direct nonmedical, and indirect costs were collected using a microcosting approach, was conducted between May 2014 and July 2016 from a societal perspective. The study population consisted of women diagnosed with ICC admitted to a tertiary hospital in Recife, state of Pernambuco, Brazil. The annual cost per patient was estimated in terms of the value of American Dollars (US$) in 2016. RESULTS: From a societal perspective, the annual ICC treatment cost per patient was US$ 2,219.73. Direct medical costs were responsible for 81.2% of the total value, of which radiotherapy and outpatient chemotherapy had the largest share. Under the base-case assumption, the estimated cost to the national budget of a year of ICC treatment in the Brazilian population was US$ 25,954,195.04. CONCLUSION: We found a high economic impact of health care systems treating ICC in a poor region of Brazil. These estimates could be applicable to further evaluations of the cost-effectiveness of preventing and treating ICC. Thieme Revinter Publicações Ltda Rio de Janeiro, Brazil.
Authors: Wânia Cristina da Silva; Brian Godman; Francisco de Assis Acúrcio; Mariângela Leal Cherchiglia; Antony Martin; Konrad Maruszczyk; Jans Bastos Izidoro; Marcos André Portella; Agner Pereira Lana; Orozimbo Henriques Campos Neto; Eli Iola Gurgel Andrade Journal: Appl Health Econ Health Policy Date: 2021-01-28 Impact factor: 2.561
Authors: Leila Abou Salha; Flávia Costa Reis; Roberta Moreira Gonçalves; Jordão Horácio da Silva Lima; Nádia Abou Salha; Roney Pereira Pinto; José Elmo de Menezes; Eduardo Perez Oliveira; Pedro Lopes Ferreira; Maria Alves Barbosa Journal: Int J Equity Health Date: 2022-08-17